Physician profile
Yasir Khan
NPI 1851605851
$12,504.92
in general payments reported to CMS, 2019-2025
28 companies · $1,073 in 2025
The $1,073 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,284 · 2020: $2,116 · 2021: $5,221 · 2022: $2,139 · 2023: $442 · 2024: $230 · 2025: $1,073.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $969 · Long Term Medical Supply Or Device Loan: $776.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $968.76 |
| Long Term Medical Supply Or Device Loan | $776.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,866.36 | 2019-2024 | Da Vinci Surgical System |
| Davol INC. | $1,866.24 | 2019-2025 | Phasix Mesh, Arista |
| Baxter Healthcare | $1,499.44 | 2019-2022 | |
| Integra Lifesciences Corporation | $976.16 | 2021-2025 | Durasorb Monofilament Mesh, Integra, Omnigraft |
| Hill-Rom Services, INC | $650.00 | 2019 | |
| Ethicon Endo-Surgery INC. | $450.00 | 2019 | |
| Boston Scientific Corporation | $190.00 | 2020 | |
| Axonics, INC. | $189.76 | 2021-2024 | Axonics |
| W. L. Gore & Associates, INC. | $142.99 | 2019-2025 | Gore Seamguard Bioabsorbable Staple Line Reinforce, Gore Enform Preperitoneal Biomaterial, Gore Synecor Biomaterial |
| Tela Bio, INC. | $119.69 | 2022-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Ethicon US, LLC | $78.51 | 2020-2023 | Linx Reflux Management System, Echelon Flex |
| Teleflex LLC | $72.10 | 2021-2025 | Titan Sgs Bailout Chuck |
| Smith+Nephew, INC. | $65.55 | 2019-2023 | Grafix Pl, Stravix |
| Daiichi Sankyo INC. | $44.56 | 2024 | Enhertu |
| Dilon Technologies, INC. | $35.76 | 2023 | Hemoblast Bellows |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Steris Corporation | $33.85 | 2019 | |
| Merck Sharp & Dohme LLC | $28.07 | 2021-2022 | |
| Innocoll Pharmaceuticals Limited | $22.50 | 2022 | |
| Sanara Medtech INC. | $21.95 | 2022 | |
| Medtronic, INC. | $21.49 | 2024 | Progrip |
| Kerecis Limited | $21.47 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Takeda Pharmaceuticals U.S.A., INC. | $18.13 | 2024 | Eohilia |
| Shire North American Group INC | $17.60 | 2019 | |
| Inspire Medical Systems, INC. | $17.41 | 2025 | Inspire |
| Avanos Medical | $14.38 | 2025 | On-Q Pump and Accessories |
| Abbvie INC. | $14.37 | 2024 | |
| Lexington Medical, INC. | $13.50 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $13.08 | 2024 | Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yasir Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.